{"entity":{"type":"insider","cik":"0001278439","url":"/insider/0001278439","json_url":"/insider/0001278439.json","name":"DENKHAUS DONALD A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":12,"first":"2008-05-19","last":"2022-11-15","span_basis":"filed_date"},"name_variants":[{"name":"DENKHAUS DONALD A","source":"filing","n_filings":12,"first_seen":"2008-05-19","last_seen":"2022-11-15"}],"transactions":[{"id":6128581,"accession":"0001161697-22-000548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000548","line_url":"/filing/0001161697-22-000548#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":16.594,"price_display":"16.59","price_state":"stated","total_value":331880.0,"total_display":"331,880.00","total_whole":"331,880","shares_owned_after":277666.0,"shares_owned_after_display":"277,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-15","scope":"insider"},{"id":6324843,"accession":"0001161697-22-000458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000458","line_url":"/filing/0001161697-22-000458#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":15.34,"price_display":"15.34","price_state":"stated","total_value":306800.0,"total_display":"306,800.00","total_whole":"306,800","shares_owned_after":297666.0,"shares_owned_after_display":"297,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-15","scope":"insider"},{"id":6067329,"accession":"0001161697-18-000634","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-18-000634","line_url":"/filing/0001161697-18-000634#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":47750.0,"total_display":"47,750.00","total_whole":"47,750","shares_owned_after":225000.0,"shares_owned_after_display":"225,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-28","scope":"insider"},{"id":6135697,"accession":"0001161697-18-000583","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-18-000583","line_url":"/filing/0001161697-18-000583#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":148800.0,"total_display":"148,800.00","total_whole":"148,800","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-17","scope":"insider"},{"id":6654894,"accession":"0001161697-18-000312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-18-000312","line_url":"/filing/0001161697-18-000312#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.41,"price_display":"3.41","price_state":"stated","total_value":68200.0,"total_display":"68,200.00","total_whole":"68,200","shares_owned_after":140000.0,"shares_owned_after_display":"140,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-11","scope":"insider"},{"id":6311705,"accession":"0001161697-18-000296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-18-000296","line_url":"/filing/0001161697-18-000296#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":120000.0,"shares_owned_after_display":"120,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-31","scope":"insider"},{"id":3250682,"accession":"0001161697-16-000885","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-16-000885","line_url":"/filing/0001161697-16-000885#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":32500.0,"total_display":"32,500.00","total_whole":"32,500","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-14","filed_date":"2016-06-14","scope":"insider"},{"id":2912446,"accession":"0001161697-16-000608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-16-000608","line_url":"/filing/0001161697-16-000608#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":50750.0,"total_display":"50,750.00","total_whole":"50,750","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-07","filed_date":"2016-01-07","scope":"insider"},{"id":8862289,"accession":"0001161697-15-000203","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000203","line_url":"/filing/0001161697-15-000203#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":16250.0,"total_display":"16,250.00","total_whole":"16,250","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-30","filed_date":"2015-04-30","scope":"insider"},{"id":8822475,"accession":"0001161697-15-000197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000197","line_url":"/filing/0001161697-15-000197#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.71,"price_display":"3.71","price_state":"stated","total_value":55650.0,"total_display":"55,650.00","total_whole":"55,650","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-27","filed_date":"2015-04-28","scope":"insider"},{"id":8877320,"accession":"0001161697-15-000144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000144","line_url":"/filing/0001161697-15-000144#line-1","is_derivative":false,"issuer_cik":"0001278439","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001278439","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.17,"price_display":"4.17","price_state":"stated","total_value":20850.0,"total_display":"20,850.00","total_whole":"20,850","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-27","filed_date":"2015-03-30","scope":"insider"},{"id":3187920,"accession":"0001209191-08-031079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-031079","line_url":"/filing/0001209191-08-031079","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":"0001278439","owner_name":"DENKHAUS DONALD A","owner_display_name":"DENKHAUS DONALD A","owner_url":"/insider/0001278439","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":10.8981,"price_display":"10.90","price_state":"stated","total_value":108981.0,"total_display":"108,981.00","total_whole":"108,981","shares_owned_after":20498.0,"shares_owned_after_display":"20,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-15","filed_date":"2008-05-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Director","n_filings":11,"first_seen":"2015-03-30","last_seen":"2022-11-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000815838","name":"NOVEN PHARMACEUTICALS INC","url":"/issuer/0000815838","role":"Director","n_filings":1,"first_seen":"2008-05-19","last_seen":"2008-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001278439","retrieved_at":"2026-08-27T20:47:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}